Concepedia

Mark A. Deeg

MA

Statistics

Publications

60

Citations

5K

H-Index

32

Active since

1981

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Eli Lilly (United States)

Indiana University School of Medicine

Richard L. Roudebush VA Medical Center

University of Washington

Mark A. Deeg is an author at Indiana University – Purdue University Indianapolis specializing in medicine, pharmacology, and physiology.

ORCID

Top concepts

Publications per year

1981–2020

60

Publications

60

The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes

Gregory Gaich, Jenny Y. Chien, Haoda Fu et al. · Cell Metabolism · 2013 · 867 citations · Full text

, , +10

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Ronald Goldberg, David M. Kendall, Mark A. Deeg et al. · Diabetes Care · 2005 · 795 citations · Full text

Ethanol Induces Fatty Acid Synthesis Pathways by Activation of Sterol Regulatory Element-binding Protein (SREBP)

Min You, Monika Fischer, Mark A. Deeg et al. · Journal of Biological Chemistry · 2002 · 540 citations · Full text

Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis

Naga Chalasani, Mark A. Deeg, David W. Crabb · The American Journal of Gastroenterology · 2004 · 340 citations

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

Christof Kazda, Ying Ding, Ronan P. Kelly et al. · Diabetes Care · 2015 · 210 citations · Full text

1–5 of 60